ADX Energy (ASX:ADX) has revealed its receipt of a favourable decision from an Austrian court, the relevant authority overseeing the company’s Austria-based Welchau project (75% owned), with appeals from environmental groups protesting plans to drill for gas back in January now effectively overturned.Listen to the HotCopper podcast for in-depth discussions and insights on all the biggest headlines from throughout the week. On Spotify, Apple, and more.Because said groups objected to already-granted environme ...

Group 1 - Chicago Atlantic BDC is structured as a business development company that generates earnings by providing capital to middle-market businesses for development and expansion [1] - The company focuses on uncovering high-quality dividend stocks and other assets that offer potential for long-term growth, aiming to enhance investment income while achieving total returns comparable to traditional index funds [1] Group 2 - The analyst emphasizes a hybrid investment strategy that combines classic dividend growth stocks with Business Development Companies, REITs, and Closed End Funds to boost income [1]

Core Viewpoint - Rosen Law Firm is reminding investors who purchased LifeMD, Inc. securities between May 7, 2025, and August 5, 2025, about the upcoming lead plaintiff deadline for a securities class action lawsuit [1]. Group 1: Class Action Details - Investors who bought LifeMD securities during the specified Class Period may be eligible for compensation without any out-of-pocket fees through a contingency fee arrangement [2]. - A class action lawsuit has already been filed, and interested parties must move the Court to serve as lead plaintiff by October 27, 2025 [3]. - The Rosen Law Firm emphasizes the importance of selecting qualified legal counsel with a successful track record in securities class actions [4]. Group 2: Case Allegations - The lawsuit alleges that defendants made materially false and misleading statements regarding LifeMD's competitive position and failed to account for rising customer acquisition costs in their 2025 guidance [5]. - It is claimed that the defendants' statements about LifeMD's business operations and prospects were materially false and misleading, leading to investor damages when the true information became public [5].

Core Insights - The gastrointestinal tolerability of ASC47 in combination with semaglutide is significantly better than that of semaglutide monotherapy, indicating a potential advantage for ASC47 in clinical applications [1] Group 1 - The incidence of vomiting in the ASC47 plus semaglutide group was 6.7%, compared to 57.1% in the semaglutide monotherapy group, highlighting a substantial difference in tolerability [1]

Satish, a graduate student from India studying in San Francisco, thought this fall would be about finishing his business degree and then lining up an H-1B visa, the work permit that’s become a mainstay for skilled immigrants in the US.Instead, he’s worried about his ability to build a career in the US as he tries to make sense of the Trump administration’s plan to raise the H-1B application fee to $100,000.Also read“When someone moves here, they move with the motive of working hard and building something be ...

Group 1 - The WisdomTree European Opportunities Fund (NYSEARCA: OPPE) is an equities exchange-traded fund that aims to track the WisdomTree European Opportunities Index [1] - Binary Tree Analytics (BTA) focuses on providing transparency and analytics in capital markets instruments and trades, particularly in closed-end funds (CEFs), exchange-traded funds (ETFs), and special situations [1] - BTA has over 20 years of investment experience and aims to deliver high annualized returns with a low volatility profile [1]

Core Viewpoint - Faraday Future Intelligent Electric Inc. is strategically investing approximately $30 million in Qualigen Therapeutics, Inc. to initiate a crypto and web3-related business, aiming to enhance its dual-flywheel and dual-bridge eco strategy to maximize shareholder value [1][2][8] Investment Details - The total investment in Qualigen Therapeutics will be around $41 million, with Faraday Future contributing about $30 million for approximately 55% of QLGN's common stock on a pro forma basis [2][3] - YT Jia, Founder & Global Co-CEO, will invest $4 million and receive about 7% of QLGN's common stock, with a two-year lockup on his shares [3][4] Management and Governance - Faraday Future plans to assign management teams to oversee relevant business activities, with YT Jia serving as chief advisor to QLGN and Jerry Wang expected to be appointed as Co-CEO [4] - Following the investment, Faraday Future will have the right to nominate two of five directors on QLGN's board, which could increase to four of seven if stockholder approval is obtained [4] Rebranding and Product Focus - Qualigen Therapeutics is expected to rebrand as CXC10, focusing on three growth engines in the crypto ecosystem, including the C10 Treasury, BesTrade DeAI Agent, and ecosystem tokens [5][6][7] - The C10 Treasury has shown an unrealized gain of around 7%, outperforming the C10 index, with a 20% actively managed allocation yielding positive results [9] Product Innovations - The FX Super One MPV was showcased at the annual 919 event, featuring an ultra-wide dual-screen panoramic display and advanced EAI OS for enhanced user interaction [10][12][13] - The EAI Space in the FX Super One is designed to provide a personalized and immersive experience, integrating hardware, software, and applications for seamless user engagement [15][16][17] Future Outlook - Faraday Future aims to bridge Web2 and Web3, as well as AI and crypto, positioning itself as a leading U.S. public company in the evolving digital landscape [6][9]

The strong booking orders come after a month-long slump. Sales to distributors, wholesalers and retailers had fallen up to 75–80% as trade partners held back purchases to take advantage of lower tax rates in GST 2.0 across categories — from small cars and television sets to coffee and subRs 2,500 apparel. Companies expect strong trade orders through the week amid Navratri and pent-up demand, as consumers had postponed big-ticket purchases in anticipation of new rates. Hyundai is expected to bill over 10,00 ...

Accessibility StatementSkip Navigation SHANGHAI, Sept. 21, 2025 /PRNewswire/ -- WuXi AppTec Co., Ltd. (Stock Codes: 603259.SH/2359.HK), a global company that provides a broad portfolio of R&D and manufacturing services to enable companies in the pharmaceutical and life science industries, implemented its first interim dividend plan, distributing a total of RMB1.03 billion in cash dividends. Also from this source WuXi AppTec Awarded Gold Medal by EcoVadis Sustainability Rating for Second Consecutive Year WuX ...

Core Viewpoint - The article discusses the potential for investing in undervalued stocks that are mispriced by the market as of the end of September [1]. Group 1 - The article suggests that investors may consider joining a platform that provides insights on undervalued stocks [1].